Revised Medical Criteria for Evaluating Cardiovascular Disorders
The FDA revised medical criteria for evaluating cardiovascular disorders under Social Security disability claims. This does not directly change dietary supplement labeling regulations, but may affect how cardiovascular health claims on supplements are evaluated in disability contexts.
Aforeworn detected this change in the Dietary-Supplement Labeling (FDA) space on July 5, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Low urgency. Supplement brands, contract manufacturers, private-label sellers, ingredient suppliers making cardiovascular health claims should confirm how it applies to their specific situation before acting. There is a time constraint attached: No immediate deadline; monitor for future FDA guidance linking these criteria to supplement claims.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Dietary-Supplement Labeling (FDA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
Updated medical criteria for evaluating cardiovascular disorders in disability claims; no direct change to FDA labeling rules for supplements.
Who it affects
Supplement brands, contract manufacturers, private-label sellers, ingredient suppliers making cardiovascular health claims
What you must do
Review any supplement labeling that includes cardiovascular health claims to ensure they are not misleading in light of updated medical criteria.
Deadline
No immediate deadline; monitor for future FDA guidance linking these criteria to supplement claims.
Never miss a change like this again
Aforeworn watches Dietary-Supplement Labeling (FDA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trial